Immutep limited

Major-Pharmaceuticals

IMMP


95 Pitt Street
Sydney , NSW 2000

Executive/
Director

Price

  • Last Close
  • $ 2.19
    $ -0.02 -0.9 %
    Jan 3, 2025
  • 52-Week High/Low
  • $2.89 - $1.76
  • YTD
  • 0.9%

  • Trading Volume
  • 121
  • Market Cap Full
  • $ 2.6B
  • Shares Outstanding
  • 1187.3M
    Jun 30, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - 21% 18.5% -5% -2.2% -17.6% -4% -2.9% 0.9%
Q2 -99.4% -99.4% 25.3% -15.3% 4% 26.1% -25.9% 25.6% -7.8% -
Q3 -99.4% -99.4% 49.8% -12.1% 8% - -23.2% -10% 13.6% -
Q4 -99.4% -8.7% -52.8% 7.4% 81.5% -14.1% 12.2% 30.4% 9.5% -
J F M A M J J A S O N D
2025 0.9% - - - - - - - - - - -
2024 -9.6% 7.8% -0.4% -3.9% - - - 13.6% - - - 6.9%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%17%-5%80%6%-47%37%-10%1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - - - - - -
Q2 - - - - - - - -
Q3 - - - - - - - -
Q4 - - - - - - - -
A 0 0 0 0 0 0 0 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - - - - - -
Jun 3026.1 3388.6 487.6 748.2 866.2 1187.3
Sep - - - - - -
Dec - - - - - -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - 0.4
Total Asset Turnover 0.1 0.1 0.4 0.2 0.2
Leverage
Interest Coverage - -2.1 -8 -12 -11
Debt Ratio - - - - 0.2
Debt – Equity Ratio - - - - 0.2
Equity multiplier - - - - 0.6